Project Number 5R01AG061151-02 Agency/Funding Organization NIA Funding Year 2020 View Full Project Details for Antisense Oligonucleotides targeting APP to prevent neurodegeneration in models of Down Syndrome and Alzheimer's disease Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 4. Non-clinical Drug Development (small molecules and biologics) a. Amyloid beta Researcher and Organization Principal Investigator MOBLEY, WILLIAM C Principal Investigator First Name WILLIAM C Principal Investigator Last Name MOBLEY Awardee Organization UNIVERSITY OF CALIFORNIA SAN DIEGO Awardee State California Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-16-041: DRUG DISCOVERY FOR NERVOUS SYSTEM DISORDERS (R01) FY Overall Cost $567,567 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official REFOLO, LORENZO Special Initiative Special Research Focus: Down Syndrome
